Ipilimumab/nivolumabAutoimmune encephalitis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1782卷 / 1期

关键词：

D O I：

10.1007/s40278-019-72355-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：186 / 186

相关论文

共 50 条

[1] Ipilimumab/nivolumabAutoimmune encephalitis: 2 case reports
Reactions Weekly, 2016, 1620 (1) : 101 - 101
[2] Ipilimumab/nivolumabAutoimmune encephalitis: case report
Reactions Weekly, 2019, 1771 (1) : 177 - 177
[3] Ipilimumab/nivolumabAutoimmune encephalitis: case report
Reactions Weekly, 2019, 1778 (1) : 258 - 258
[4] Ipilimumab/nivolumabAutoimmune encephalitis: case report
Reactions Weekly, 2022, 1902 (1) : 253 - 253
[5] Ipilimumab/nivolumabAutoimmune encephalitis: case report
Reactions Weekly, 2021, 1866 (1) : 225 - 225
[6] Ipilimumab/nivolumabAutoimmune encephalitis: case report
Reactions Weekly, 2021, 1847 (1) : 257 - 257
[7] Durvalumab/ipilimumab/nivolumabAutoimmune autonomic ganglionopathy, autoimmune encephalitis or skin rash: 2 case reports
Reactions Weekly, 2023, 1965 (1) : 191 - 191
[8] Ipilimumab/nivolumabAutoimmune hepatitis: case report
Reactions Weekly, 2022, 1889 (1) : 182 - 182
[9] Ipilimumab/nivolumabAutoimmune pneumonitis: case report
Reactions Weekly, 2023, 1950 (1) : 229 - 229
[10] Ipilimumab/nivolumabAutoimmune colitis: case report
Reactions Weekly, 2020, 1807 (1) : 103 - 103

← 1 2 3 4 5 →